| 摘要 |
The present invention provides methods for the treatment, and pharmaceutical s for the use in the treatment, of mammalian subjects having, or at risk of developing, glomerulonephritis or chronic renal failure. The methods involve the administration of IFN-.beta. therapeutics.
|
